Compile Data Set for Download or QSAR
Report error Found 65 Enz. Inhib. hit(s) with all data for entry = 11572
TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627551(US11793823, Compound 123)
Affinity DataIC50: 2.40nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627549(US11793823, Compound 121)
Affinity DataIC50: 2.5nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627557(US11793823, Compound 140)
Affinity DataIC50: 3nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627553(US11793823, Compound 128)
Affinity DataIC50: 3.30nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627552(US11793823, Compound 126)
Affinity DataIC50: 3.60nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627561(US11793823, Compound 148)
Affinity DataIC50: 4nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627556(US11793823, Compound 138)
Affinity DataIC50: 4nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627560(US11793823, Compound 146)
Affinity DataIC50: 4nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627548(US11793823, Compound 119)
Affinity DataIC50: 5nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627555(US11793823, Compound 136)
Affinity DataIC50: 6nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627546(US11793823, Compound 107)
Affinity DataIC50: 7nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627545(US11793823, Compound 103)
Affinity DataIC50: 7nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627559(US11793823, Compound 144)
Affinity DataIC50: 8nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627554(US11793823, Compound 134)
Affinity DataIC50: 8nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627547(US11793823, Compound 117)
Affinity DataIC50: 9nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627544(US11793823, Compound 100)
Affinity DataIC50: 19nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627558(US11793823, Compound 142)
Affinity DataIC50: 19nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627540(US11793823, Compound 92)
Affinity DataIC50: 23nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627535(US11793823, Compound 66)
Affinity DataIC50: 25nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627542(US11793823, Compound 96)
Affinity DataIC50: 26nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627539(US11793823, Compound 85)
Affinity DataIC50: 31nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627536(US11793823, Compound 74)
Affinity DataIC50: 31nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627532(US11793823, Compound 42)
Affinity DataIC50: 31nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627543(US11793823, Compound 98)
Affinity DataIC50: 33nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627534(US11793823, Compound 58)
Affinity DataIC50: 33nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627533(US11793823, Compound 50)
Affinity DataIC50: 38nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627541(US11793823, Compound 94)
Affinity DataIC50: 42nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627562(US11793823, Compound 149)
Affinity DataIC50: 48nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627538(US11793823, Compound 80)
Affinity DataIC50: 58nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627527(US11793823, Compound 22)
Affinity DataIC50: 63nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627531(US11793823, Compound 34)
Affinity DataIC50: 68nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627537(US11793823, Compound 77)
Affinity DataIC50: 72nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627529(US11793823, Compound 28)
Affinity DataIC50: 82nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627528(US11793823, Compound 25)
Affinity DataIC50: 89nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627526(US11793823, Compound 18)
Affinity DataIC50: 121nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetD-amino-acid oxidase(Human)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627525(US11793823, Compound 14)
Affinity DataIC50: 299nMAssay Description:The hDAAO inhibitory activities were measured by using D-Serine as a substrate to produce H2O2. The produced H2O2 would be oxidized by peroxidase, an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627551(US11793823, Compound 123)
Affinity DataIC50: 380nMAssay Description:To study the inhibitory activities against SARS-CoV-2 3CLPro of test compounds, an assay was determined in vitro by measuring the enhanced fluorescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627548(US11793823, Compound 119)
Affinity DataIC50: 526nMAssay Description:To study the inhibitory activities against SARS-CoV-2 3CLPro of test compounds, an assay was determined in vitro by measuring the enhanced fluorescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627556(US11793823, Compound 138)
Affinity DataIC50: 552nMAssay Description:To study the inhibitory activities against SARS-CoV-2 3CLPro of test compounds, an assay was determined in vitro by measuring the enhanced fluorescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627549(US11793823, Compound 121)
Affinity DataIC50: 585nMAssay Description:To study the inhibitory activities against SARS-CoV-2 3CLPro of test compounds, an assay was determined in vitro by measuring the enhanced fluorescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627553(US11793823, Compound 128)
Affinity DataIC50: 604nMAssay Description:To study the inhibitory activities against SARS-CoV-2 3CLPro of test compounds, an assay was determined in vitro by measuring the enhanced fluorescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627557(US11793823, Compound 140)
Affinity DataIC50: 658nMAssay Description:To study the inhibitory activities against SARS-CoV-2 3CLPro of test compounds, an assay was determined in vitro by measuring the enhanced fluorescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627552(US11793823, Compound 126)
Affinity DataIC50: 706nMAssay Description:To study the inhibitory activities against SARS-CoV-2 3CLPro of test compounds, an assay was determined in vitro by measuring the enhanced fluorescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627561(US11793823, Compound 148)
Affinity DataIC50: 724nMAssay Description:To study the inhibitory activities against SARS-CoV-2 3CLPro of test compounds, an assay was determined in vitro by measuring the enhanced fluorescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627555(US11793823, Compound 136)
Affinity DataIC50: 841nMAssay Description:To study the inhibitory activities against SARS-CoV-2 3CLPro of test compounds, an assay was determined in vitro by measuring the enhanced fluorescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627559(US11793823, Compound 144)
Affinity DataIC50: 870nMAssay Description:To study the inhibitory activities against SARS-CoV-2 3CLPro of test compounds, an assay was determined in vitro by measuring the enhanced fluorescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627563(tannic acid | US11793823, Compound SNB01)
Affinity DataIC50: 924nMAssay Description:To study the inhibitory activities against SARS-CoV-2 3CLPro of test compounds, an assay was determined in vitro by measuring the enhanced fluorescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627554(US11793823, Compound 134)
Affinity DataIC50: 1.02E+3nMAssay Description:To study the inhibitory activities against SARS-CoV-2 3CLPro of test compounds, an assay was determined in vitro by measuring the enhanced fluorescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627547(US11793823, Compound 117)
Affinity DataIC50: 1.24E+3nMAssay Description:To study the inhibitory activities against SARS-CoV-2 3CLPro of test compounds, an assay was determined in vitro by measuring the enhanced fluorescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
SyneuRx International (Taiwan)

US Patent
LigandPNGBDBM627560(US11793823, Compound 146)
Affinity DataIC50: 1.53E+3nMAssay Description:To study the inhibitory activities against SARS-CoV-2 3CLPro of test compounds, an assay was determined in vitro by measuring the enhanced fluorescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
Go to US Patent

Displayed 1 to 50 (of 65 total ) | Next | Last >>
Jump to: